Rakuhei Nakama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rakuhei Nakama has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Kenichi Kase
Department of Emergency Medicine and Critical Care Medicine, Saiseikai Utsunomiya Hospital
4 shared publications- Tatsushi Kobayashi
Department of Diagnostic Radiology, National Cancer Center Hospital East, Kashiwa, Japan
4 shared publications Yasunori Arai
Department of Diagnostic Radiology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan
4 shared publicationsKeiichi Tanimura
Saiseikai Utsunomiya Byoin
3 shared publicationsToshiaki Yagami
Department of Radiology, Saiseikai Utsunomiya Hospital
3 shared publications- Chihiro Itou
Department of Diagnostic and Interventional Radiology, National Cancer Center Hospital, Tokyo, Japan
2 shared publications
Latest Publications
- Open Access
- 12 September 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (12)
Safety Profile of Imipenem/Cilastatin as an Embolic Agent for Intestinal Embolization: Preclinical Evaluation in a Swine Model
- 12 September 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (12)
Open AccessSafety Profile of Imipenem/Cilastatin as an Embolic Agent for Intestinal Embolization: Preclinical Evaluation in a Swine Model
- Open Access
- 29 March 2025
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 43 (8) , 1380-1385
Investigation of tube replacement cases of percutaneous transesophageal gastro-tubing in cancer patients
Purpose: Percutaneous transesophageal gastro-tubing (PTEG) is an interventional radiology technique used for enteral feeding, or drainage in malignant bowel syndrome cases, serving as an alternative to percutaneous gastrostomy. Despite its safety and effectiveness in improving quality of life, comprehensive studies on PTEG tube replacement are limited. This study aimed to investigate the cases of PTEG tube replacement. Material and methods: This single-center retrospective cohort study was conducted at the National Cancer Center Hospital, Tokyo, Japan. Data were collected from patients who underwent PTEG for malignant bowel obstruction or enteral feeding and then required tube replacement between January 1, 2014 and December 31, 2023. Patient characteristics, duration of tube indwelling, PTEG tube tip position, causes of replacement, and whether dilation or re-PTEG was performed during replacement were analyzed, excluding patients who were transferred or deceased before the initial replacement. Statistical analyses were performed using the Chi-square, Fisher's exact, and Mann–Whitney U tests, with significance set at P < 0.05. Results: Of 236 patients who underwent PTEG, 56 required an initial tube replacement. The mean age was 55 years, with 51.8 % of patients predominantly male. The primary indication for PTEG was decompression (52 patients). The median tube indwelling duration was 31 days, with the tube tip positioned in the gastric or duodenal in 64.3 % of cases. The most frequent reason for common replacement procedures, performed in 44 patients, was tube dysfunction. Replacement due to accidental removal in 12 patients led to higher rates of dilation or re-PTEG. The duration after accidental removal significantly affected the necessity for dilation or re-PTEG. Conclusion: This study on initial PTEG tube replacement in cancer patients indicated that tube dysfunction is the primary reason for replacement, and accidental removal is more likely to require dilation or re-PTEG.
- 29 March 2025
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 43 (8) , 1380-1385
Open AccessInvestigation of tube replacement cases of percutaneous transesophageal gastro-tubing in cancer patients
Purpose: Percutaneous transesophageal gastro-tubing (PTEG) is an interventional radiology technique used for enteral feeding, or drainage in malignant bowel syndrome cases, serving as an alternative to percutaneous gastrostomy. Despite its safety and effectiveness in improving quality of life, comprehensive studies on PTEG tube replacement are limited. This study aimed to investigate the cases of PTEG tube replacement. Material and methods: This single-center retrospective cohort study was conducted at the National Cancer Center Hospital, Tokyo, Japan. Data were collected from patients who underwent PTEG for malignant bowel obstruction or enteral feeding and then required tube replacement between January 1, 2014 and December 31, 2023. Patient characteristics, duration of tube indwelling, PTEG tube tip position, causes of replacement, and whether dilation or re-PTEG was performed during replacement were analyzed, excluding patients who were transferred or deceased before the initial replacement. Statistical analyses were performed using the Chi-square, Fisher's exact, and Mann–Whitney U tests, with significance set at P < 0.05. Results: Of 236 patients who underwent PTEG, 56 required an initial tube replacement. The mean age was 55 years, with 51.8 % of patients predominantly male. The primary indication for PTEG was decompression (52 patients). The median tube indwelling duration was 31 days, with the tube tip positioned in the gastric or duodenal in 64.3 % of cases. The most frequent reason for common replacement procedures, performed in 44 patients, was tube dysfunction. Replacement due to accidental removal in 12 patients led to higher rates of dilation or re-PTEG. The duration after accidental removal significantly affected the necessity for dilation or re-PTEG. Conclusion: This study on initial PTEG tube replacement in cancer patients indicated that tube dysfunction is the primary reason for replacement, and accidental removal is more likely to require dilation or re-PTEG.
- Open Access
- 14 November 2024
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 43 (4) , 696-705
Risk factors of non-diagnostic percutaneous liver tumor biopsy: a single-center retrospective analysis of 938 biopsies based on cause of error
Purpose: To evaluate the risk factors of non-diagnostic results based on cause of error in liver tumor biopsy. Materials and methods: This single-institution, retrospective study included 843 patients [445 men, 398 women; median age, 67 years] who underwent a total of 938 liver tumor biopsies between April 2018 and September 2022. An 18-G cutting biopsy needle with a 17-G introducer needle was used. Ultrasound was used as the first choice for image guidance, and computed tomography was alternatively or complementarily used only for tumors with poor ultrasound visibility. Non-diagnostic biopsies were divided into two groups depending on the cause of error, either technical or targeting error. Biopsies in which the biopsy needle did not hit the target tumor were classified as technical error. Biopsies in which insufficient tissue was obtained due to necrosis or degeneration despite the biopsy needle hitting the target tumor were classified as targeting error. This classification was based on pre-procedural enhanced-imaging, intro-procedural imaging, and pathological findings. Statistical analysis was performed using binary logistic regression. Results: The non-diagnostic rate was 4.6%. Twenty-six and seventeen biopsies were classified as technical and targeting errors, respectively. In the technical error group, tumor size ≤ 17 mm and computed tomography-assisted biopsy due to poor ultrasound visibility were identified as risk factors (p < 0.001 and p = 0.021, respectively), and the tumors with both factors had a significantly high risk of technical error compared to those without both factors (non-diagnostic rate: 17.2 vs 1.1%, p < 0.001). In the targeting error group, tumor size ≥ 42 mm was identified as a risk factor (p = 0.003). Conclusion: Tumor size ≤ 17 mm and computed tomography-assisted biopsy due to poor ultrasound visibility were risk factors for technical error, and tumor size ≥ 42 mm was a risk factor for targeting error in liver tumor biopsies.
- 14 November 2024
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 43 (4) , 696-705
Open AccessRisk factors of non-diagnostic percutaneous liver tumor biopsy: a single-center retrospective analysis of 938 biopsies based on cause of error
Purpose: To evaluate the risk factors of non-diagnostic results based on cause of error in liver tumor biopsy. Materials and methods: This single-institution, retrospective study included 843 patients [445 men, 398 women; median age, 67 years] who underwent a total of 938 liver tumor biopsies between April 2018 and September 2022. An 18-G cutting biopsy needle with a 17-G introducer needle was used. Ultrasound was used as the first choice for image guidance, and computed tomography was alternatively or complementarily used only for tumors with poor ultrasound visibility. Non-diagnostic biopsies were divided into two groups depending on the cause of error, either technical or targeting error. Biopsies in which the biopsy needle did not hit the target tumor were classified as technical error. Biopsies in which insufficient tissue was obtained due to necrosis or degeneration despite the biopsy needle hitting the target tumor were classified as targeting error. This classification was based on pre-procedural enhanced-imaging, intro-procedural imaging, and pathological findings. Statistical analysis was performed using binary logistic regression. Results: The non-diagnostic rate was 4.6%. Twenty-six and seventeen biopsies were classified as technical and targeting errors, respectively. In the technical error group, tumor size ≤ 17 mm and computed tomography-assisted biopsy due to poor ultrasound visibility were identified as risk factors (p < 0.001 and p = 0.021, respectively), and the tumors with both factors had a significantly high risk of technical error compared to those without both factors (non-diagnostic rate: 17.2 vs 1.1%, p < 0.001). In the targeting error group, tumor size ≥ 42 mm was identified as a risk factor (p = 0.003). Conclusion: Tumor size ≤ 17 mm and computed tomography-assisted biopsy due to poor ultrasound visibility were risk factors for technical error, and tumor size ≥ 42 mm was a risk factor for targeting error in liver tumor biopsies.
- Open Access
- 16 January 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (4) , 1440-1444
Computed tomography-guided percutaneous needle biopsy for middle mediastinal tumors with retroaortic paravertebral approach: A case report
- 16 January 2024
- Published by Elsevier in Radiology Case Reports
- Vol. 19 (4) , 1440-1444
Open AccessComputed tomography-guided percutaneous needle biopsy for middle mediastinal tumors with retroaortic paravertebral approach: A case report
- Open Access
- 1 May 2023
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (9) , 1383-1384
Air Embolism with Electrocardiogram Abnormality after Lung Biopsy
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 1 May 2023
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (9) , 1383-1384
Open AccessAir Embolism with Electrocardiogram Abnormality after Lung Biopsy
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- Open Access
- 1 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32118
Blast Injuries by an Improvised Explosive Device in Japan: A Case Report
Blast injuries caused by an improvised explosive device (IED) are becoming more common in civilian settings. However, physicians may not be familiar with the treatment and management of blast-injured victims. To the best of our knowledge, this is the first case report of a blast injury caused by an IED in Japan. A 64-year-old man was admitted to our hospital’s emergency department after sustaining a blast injury. His vital signs were stable, but he had multiple small wounds with embedded foreign bodies that were consistent with injuries sustained by IED victims. The patient was treated for his injuries and was moved to another hospital on day 37. Knowledge about blast injuries caused by IEDs and management strategies for mass casualties are both necessary.
- 1 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32118
Open AccessBlast Injuries by an Improvised Explosive Device in Japan: A Case Report
Blast injuries caused by an improvised explosive device (IED) are becoming more common in civilian settings. However, physicians may not be familiar with the treatment and management of blast-injured victims. To the best of our knowledge, this is the first case report of a blast injury caused by an IED in Japan. A 64-year-old man was admitted to our hospital’s emergency department after sustaining a blast injury. His vital signs were stable, but he had multiple small wounds with embedded foreign bodies that were consistent with injuries sustained by IED victims. The patient was treated for his injuries and was moved to another hospital on day 37. Knowledge about blast injuries caused by IEDs and management strategies for mass casualties are both necessary.
- Open Access
- 25 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24466
Sedation With Dexmedetomidine During Lymphangiography and Thoracic Duct Embolization in an Elderly Man
An 83-year-old man underwent cervical esophagectomy and developed a chylothorax as a postoperative complication. We decided to perform lymphangiography and thoracic duct embolization for chylous leakage, but it was expected to be challenging to maintain bed rest. Therefore, dexmedetomidine was administered for procedural sedation. The patient’s blood pressure and heart rate were mostly stable during the procedure, and the sedation level was maintained within the desired limits. Due to its specific sedative pattern and mild analgesic effect, Dexmedetomidine is suitable for procedural sedation in various painless interventional radiology procedures, such as lymphangiography and thoracic duct embolization. Therefore, it may be the best sedative for the elderly and should be widely and effectively used in interventional radiology.
- 25 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24466
Open AccessSedation With Dexmedetomidine During Lymphangiography and Thoracic Duct Embolization in an Elderly Man
An 83-year-old man underwent cervical esophagectomy and developed a chylothorax as a postoperative complication. We decided to perform lymphangiography and thoracic duct embolization for chylous leakage, but it was expected to be challenging to maintain bed rest. Therefore, dexmedetomidine was administered for procedural sedation. The patient’s blood pressure and heart rate were mostly stable during the procedure, and the sedation level was maintained within the desired limits. Due to its specific sedative pattern and mild analgesic effect, Dexmedetomidine is suitable for procedural sedation in various painless interventional radiology procedures, such as lymphangiography and thoracic duct embolization. Therefore, it may be the best sedative for the elderly and should be widely and effectively used in interventional radiology.
- 18 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (7) , 854-855
Computed Tomography–Guided Percutaneous Intranodal Mesenteric Lymphangiography for the Identification of a Lymphatic Leak
- 18 April 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (7) , 854-855
Computed Tomography–Guided Percutaneous Intranodal Mesenteric Lymphangiography for the Identification of a Lymphatic Leak
- Open Access
- 1 September 2021
- Published by Elsevier in Urology Case Reports
- Vol. 38, 101726
Successful transcatheter arterial embolization for uretero-inferior epigastric arterial fistula: A rare complication of cutaneous ureterostomy
- 1 September 2021
- Published by Elsevier in Urology Case Reports
- Vol. 38, 101726
Open AccessSuccessful transcatheter arterial embolization for uretero-inferior epigastric arterial fistula: A rare complication of cutaneous ureterostomy